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Hypoglycemia and mortality in 
hyperglycemic patients hospitalized 
with acute myocardial infarction
Kosiborod et al., JAMA 2009; 301: 1556–1564; doi:10.1001/jama.2009.496
The results of studies of intensive glucose control in both inpatients 
and outpatients have been conflicting and controversial. Among the 
inpatient critically ill, clinical trials provide conflicting results as to 
whether intensive control improves mortality.1,2 Among outpatients, 
a trial assessing intensive glucose control was stopped early because 
of an increased risk of mortality.3 A new retrospective cohort study 
uses data from a database of patients across the United States in 
40 hospitals between 1 January 2000 and 31 December 2005. A 
total of 7820 patients hospitalized with acute myocardial infarction 
were hyperglycemic (>140 mg/dl) on admission. A hypoglycemic 
event was defined as a random glucose level less than 60 mg/dl. The 
association between hypoglycemia and in-hospital mortality was 
assessed by logistic regression among the cohort overall and among 
subgroups of patients who did or did not receive insulin therapy. 
Patients who developed hypoglycemia were, in general, older and 
had more comorbidities. Importantly, patients who developed 
hypoglycemia had higher admission creatinine measurements and 
were more likely to have acute kidney injury regardless of whether 
they received insulin. Hypoglycemia was associated with increased 
mortality only in patients not treated with insulin (18.4% mortality 
in patients with hypoglycemia versus 9.2% in those without hypogly-
cemia). No difference in mortality was demonstrated among patients 
treated with insulin whether or not they developed hypoglycemia as 
a result of receiving insulin (iatrogenic hypoglycemia).
Prior studies have shown conflicting results regarding the risk of 
mortality when using insulin to achieve intensive glucose control. 
This article, however, strongly suggests that the possible risk of mor-
tality is not caused by iatrogenic hypoglycemia, which can result 
from insulin therapy.
Lynda Szczech
1J Am Soc Nephrol 2008; 19: 571–578. 2N Engl J Med 2009; 360: 1283–1297.  
3N Engl J Med 2008; 358: 2560–2572.
Role of Kv1.1 voltage-gated 
potassium channel in renal 
magnesium reabsorption
Glaudemans et al., J Clin Invest 2009; 119: 936–942; doi:10.1172/JCI36948
Primary hypomagnesemia is a heterogeneous group of rare disor-
ders characterized by renal or intestinal magnesium (Mg2+) wasting 
that can result in tetany, cardiac arrhythmias, and seizures. However, 
hypomagnesemia has been estimated to occur in approximately 2% 
of the general population, and in more than 10% of hospitalized 
patients, although it has been found at a frequency as high as 60% of 
patients admitted in intensive care units. The kidney is essential for 
the maintenance of normal Mg2+ balance. Like many ions, the bulk 
of the filtered Mg2+ is reabsorbed along the proximal tubule and thick 
ascending limb of Henle’s loop. It is currently believed that fine-tuning 
of urinary Mg2+ excretion occurs in the distal convoluted tubule in an 
active transcellular fashion initiated by the Mg2+-permeable transient 
receptor potential cation channel, subfamily M, member 6 (TRPM6). 
Because both extra- and intracellular Mg2+ concentrations are in the 
millimolar range, it has been assumed that the membrane potential 
across the luminal membrane acts as the primary driving force for 
Mg2+ entry via TRPM6. Genetic studies in families with hereditary 
renal Mg2+ wasting syndromes have revealed several genes involved in 
Mg2+ homeostasis, including the tight junction proteins claudin 16 and 
claudin 19, the thiazide-sensitive sodium chloride cotransporter, the 
γ-subunit of the Na+/K+-ATPase, TRPM6, and the recently discovered 
magnesiotropic hormone EGF. Despite these discoveries, knowledge 
of renal Mg2+ handling remains far from complete. Glaudemans et al. 
screened a large Brazilian family with autosomal dominant hypomag-
nesemia. The family had 46 members, of whom 21 were affected and 
showed low serum Mg2+ levels with normal urinary Mg2+ excretion, 
suggesting impaired tubular Mg2+ reabsorption. The authors used a 
positional cloning approach to identify an N255D mutation in KCNA1, 
a gene encoding the voltage-gated potassium (K+) channel Kv1.1. Kv1.1 
was found to be expressed in the kidney, where it colocalized with 
TRPM6 along the luminal membrane of the distal convoluted tubule. 
Upon overexpression in a human kidney cell line, patch clamp analysis 
revealed that the KCNA1 N255D mutation resulted in a nonfunctional 
channel, with a dominant-negative effect on wild-type Kv1.1 channel 
function. These data (Figure) strongly suggest that Kv1.1 establishes a 
favorable luminal membrane potential in distal convoluted tubule cells 
to control TRPM6-mediated Mg2+ reabsorption.
Juan Oliver
Blocking the c-Jun amino terminal 
kinase ameliorates anti-GBM 
glomerulonephritis
Ma et al., Lab Invest 2009; 89: 470–484; doi:10.1038/labinvest.2009.2
The accumulation of monocyte/macrophages within the glomeru-
lus and tubulointerstitium is associated with renal injury and the 
Schematic model of the Mg2+-reabsorbing distal convoluted tubule cell 
in the kidney.
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progression of many forms of human glomerulonephritis. This 
action occurs partially via activation of the c-Jun amino termi-
nal kinase (JNK) signaling pathway. However, the efficacy of JNK 
inhibition once the proinflammatory response is established in the 
injured kidney is not known. A new study by Ma et al. looked at 
whether blockade of JNK signaling could stop crescent formation 
and hence disease progression. The authors immunized WKY rats 
with sheep IgG and then injected them with sheep anti-glomerular 
basement membrane (GBM) serum. Then, they were given the 
JNK inhibitor CC-401, vehicle alone, or no treatment until they 
were killed after developing disease (Figure). Untreated animals 
at day 7 had developed significant proteinuria, focal glomerular 
lesions, marked glomerular macrophage and T-cell accumulation, 
and upregulation of proinflammatory mediators (tumor necro-
sis factor-α (TNF-α), inducible nitric oxide synthase (iNOS), 
and matrix metalloproteinase-12 (MMP-12)). The untreated 
and vehicle-treated groups had severe glomerulonephritis, renal 
impairment, and worsening proteinuria at day 24. These animals 
had severe glomerular lesions; 60% of the glomeruli exhibited fibro-
cellular crescents, which were associated with increased macro-
phage and T-cell accumulation (including macrophage giant cells) 
and further increases in mRNA levels of TNF-α, iNOS, MMP-12, 
and transforming growth factor-b1. In contrast, CC-401 treatment 
prevented renal impairment and suppressed proteinuria and severe 
glomerular and tubulointerstitial lesions, including crescent forma-
tion and granulomatous-like lesions. These benefits occurred inde-
pendent of glomerular macrophage and T-cell accumulation and 
humoral immune response. CC-401 treatment led to the expression 
of both pro- and anti-inflammatory molecules (interleukin (IL)-10 
and heme oxygenase-1). In addition, MMP-12 and IL-10 induced 
by IL-1 and produced by cultured macrophages were found to be 
dependent on JNK. The authors conclude that blockade of JNK 
signaling protects against the progression of crescentic anti-GBM 
glomerulonephritis. This effect may be due, at least in part, to inhi-
bition of the macrophage proinflammatory response.
Marc De Broe
Selectivity of  
gas-conducting channels
Musa-Aziz et al., Proc Natl Acad Sci USA 2009; 106: 5406–5411; doi:10.1073/
pnas.0813231106
Transport of gases such as carbon dioxide (CO2), oxygen, nitrogen, 
ammonia (NH3), and nitric oxide (NO) through cell membranes 
is of fundamental importance for many biological functions. As 
with other molecules soluble in lipids, it had long been assumed 
that the pathway for the transport of these gases across cell mem-
branes was the lipid bilayer, since they are sufficiently lipid soluble 
to allow rapid permeation. However, as Al-Awqati has argued,1 the 
assumption that lipid-soluble molecules merely diffuse through 
the lipid phase of the cell membrane has been called into ques-
tion by a growing body of evidence. Critical observations con-
cerning gases include the findings that the apical membranes of 
gastric-gland cells have no demonstrable permeability to CO2 
or NH3 and that heterologous expression of the water channel 
aquaporin 1 (AQP1) increased the CO2 permeability of Xenopus 
oocytes. Other experiments showed that AQP1 is permeable to 
NO, and that AQP1, AQP3, AQP8, and AQP9 are all permeable 
to NH3. The Rhesus (Rh) proteins are a second family of gas chan-
nels also permeable to CO2 and NH3, one of which (Rhcg) was 
recently found to be critical for renal. NH3 transport. In a new 
communication, Musa-Aziz et al. assess the relative permeabili-
ties of CO2 versus NH3 in Xenopus oocytes expressing members 
of the AQP or the Rh family. They found that AQP1, but not the 
sodium-dependent glucose transporter SGLT1, the sodium-potas-
sium-chloride cotransporter NKCC2, or the hydrogen+/peptide 
symporter PepT1, conducted CO2 and NH3. In addition, oocytes 
expressing rat AQP4, rat AQP5, human RhAG, or the bacterial Rh 
homologue AmtB exhibited greater CO2 permeability than con-
trols. Finally, oocytes expressing AmtB and RhAG, but not AQP4 
or AQP5, had greater NH3 values. Only AQPs demonstrated sig-
nificant osmotic water permeability. Results are summarized in 
the Figure, which illustrates that each channel exhibited a char-
acteristic ratio for indexes of CO2 versus NH3 permeability. Thus, 
like ion channels, gas channels exhibit selectivity.
Juan Oliver
1Nat Cell Biol 1999; 1: E201–E202.
Renal damage assessed on PAS-stained sections.
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Comparison of channel-dependent properties. (a) Indexes of channel-
dependent CO2 permeability. (b) Indexes of channel-dependent NH3 
permeability. (c) Channel-dependent water permeabilities. Oocytes in a 
are the same as those in b and c. ∆pHS*, channel-dependent change in 
surface pH; Pf*, channel-dependent osmotic water permeability.
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